XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue- Provention (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Nov. 30, 2022
May 31, 2018
Mar. 31, 2023
Mar. 31, 2022
Collaboration And Other Agreements [Line Items]        
Revenues     $ 24,496 $ 11,101
Provention Bio        
Collaboration And Other Agreements [Line Items]        
Collaborative agreement transaction price   $ 6,100    
Collaborative Agreement Consideration Received Common Stock Warrants Number Of Shares   2,432,688    
Provention Bio | Revenues From License Agreements        
Collaboration And Other Agreements [Line Items]        
Revenues   $ 6,100    
Provention Bio | Provention PRV3279 | Provention License Agreement        
Collaboration And Other Agreements [Line Items]        
Collaborative Agreement Consideration Received Common Stock Warrant Exercise Price Per Share   $ 2.5    
Potential development and regulatory milestone payments under agreement   $ 65,000    
Potential commercial milestone payments under agreement   $ 225,000    
Provention Bio | Provention PRV031 | Asset Purchase Agreement        
Collaboration And Other Agreements [Line Items]        
Collaborative Agreement Consideration Received Common Stock Warrant Exercise Price Per Share   $ 2.5    
Potential development and regulatory milestone payments under agreement   $ 170,000    
Potential commercial milestone payments under agreement   225,000    
Development and regulatory milestones recognized $ 60,000      
Potential Milestone Payment To Third Parties For Intellectual Property Under Agreement   $ 1,300    
Revenues     400  
Receivable from collaboration partner     $ 30,000